Skip to content

Observational Study on Contraception With Essure in France

Survey on Use and Characteristics of Definitive Contraception With ESsure®

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02510443
Acronym
SUCCES II
Enrollment
2644
Registered
2015-07-29
Start date
2008-06-23
Completion date
2016-11-25
Last updated
2017-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Permanent contraception method, Contraceptive device

Brief summary

Using a very broad survey, the objective is to confirm the effectiveness of the Essure method, and to obtain more information on the conditions of use as well as on the methods used during the 3-month check-up, as well as the 12-month, 24-month and 5-year follow-up on patients.

Detailed description

The study is a prospective epidemiological survey to collect local real life data on patients under routine pratice

Interventions

Bilateral insert placement

Sponsors

Hôpital André Mignot Centre Hospitalier de Versailles
CollaboratorUNKNOWN
Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Woman ≥ 18 years old, * Scheduled for Essure procedure * Patient who has been given appropriate information about the study objectives and procedures and who has given her consent.

Exclusion criteria

* Patients with contraindications as listed in the current Instruction For Use (IFU) will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients being satisfied with successful Essure procedure having no complications at 5 yearsAt 5 yearsPatient satisfaction will be assessed on a Likert scale. Complications are migration/expulsion of Essure, infection. Pregnancy will be measured at any time Point.

Secondary

MeasureTime frameDescription
Number of unsatisfied patientsUp to 5 years
Number of satisfied patients at 3, 12 and 24 monthsAt 3 ,12 and 24 monthsPatients satisfaction assessed by Likert scale.
Number of examinations by patientsAt 3 months
Number of patients with moderate or important pain when placement is performedAt initial visitVisual Analogue Scale (VAS) use to report the pain from 0 (no pain) to 10 (maximal pain). Moderate pain will range from 4 to 6 and important pain will range from 7 to 10 on the VAS.
Causes of unsatisfied patientsUp to 5 yearsPossible causes of unsatisfaction : pregnancy, regret of the patient,migration/expulsion of Essure,or infection
Type of examinations by patientsAt 3 monthsUltrasound transvaginale, radiography, or hysterosalpingography (HSG)
Number of patients with regretsAt 12 months, 24 months and 5 years
Number of good insert position by implant and patients with success in final result of the procedureAt 3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026